EP 1464333 A2 20041006 - Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders
Title (en)
Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders
Title (de)
Verwendung von optisch reines (-) Norcisapride in der Behandlung von Apnea, Bulimia und andere Krankheiten
Title (fr)
Procedes permettant de traiter l'apnee, la boulimie et d'autres troubles au moyen du norcisapride (-) optiquement pur
Publication
Application
Priority
- EP 99930196 A 19990610
- US 8922598 P 19980615
- US 12223699 P 19990301
Abstract (en)
Methods for the prevention, treatment or management of apnea, apnea disorders, bulimia nervosa, irritable bowel syndrome, urinary incontinence, bradycardia, bradyarrhythmia, syncope, other disorders, or symptoms thereof using (-) norcisapride, or a pharmaceutically acceptable salt thereof, substantially free of its (+) stereoisomer.
IPC 1-7
IPC 8 full level
A61K 31/445 (2006.01); A61K 31/4468 (2006.01)
CPC (source: EP)
A61K 31/445 (2013.01); A61K 31/4468 (2013.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
DOCDB simple family (application)
EP 04014423 A 19990610